NasdaqGM:HROWPharmaceuticals
Will Harrow's (HROW) Return to Profitability Reshape Its Growth Narrative?
Harrow, Inc. recently reported its third quarter 2025 financial results, posting revenue of US$71.64 million and achieving net income of US$1.02 million after a net loss in the prior year.
This marks a shift in profitability for the company, with a swing from a net loss a year ago to positive earnings this quarter.
Following this return to profitability, we'll examine how these results influence Harrow's investment narrative and future growth outlook.
Find companies with promising cash flow...